Artios Pharma Raises $115 Million in Series D Financing to Advance Clinical Programs

Cooley has advised Artios Pharma, while Sidley and Brown Rudnick have advised RA Capital Management. DLA Piper has advised Pfizer Venture. Artios Pharma Limited has closed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here